City Therapeutics Revenue

Biotechnology Research • United States • 51-100 Employees

City Therapeutics revenue & valuation

Annual revenue	$5,475,520
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$17,600,000
Total funding	$135,000,000

Key Contacts at City Therapeutics

Fred Briones

Senior Director Cmc

Nicolas Lonfat

Director, Biology

Andy Hoss

Director, Data Science

Jay Wang

Associate Director

Guoqing Sheng

Senior Medical Director

Noriyuki Kawahata

Executive Director, Program & Alliance Management

Ceren Ergorul

Senior Director, Nonclinical Safety Evaluation, Translational Sciences

Sean Spingler

Senior Director Information Technology

Nabanita De

Associate Director

Kenneth Kelly

Associate Director, Liver Biology

Company overview

Headquarters	United States
Website	citytx.com
NAICS	541714
Employees	51-100
Socials

City Therapeutics Email Formats

City Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@citytx.com), used 49.1% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@citytx.com	49.1%
{first name}{last name}	johndoe@citytx.com	40.4%
{last name}{last name}	doedoe@citytx.com	10.5%

About City Therapeutics

Founded by pioneering executives and scientists in RNAi, City Therapeutics is advancing next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to improve and expand the reach of RNAi-based medicines. City’s mission is to build the leading next-generation RNAi therapeutics company, unlocking RNAi’s transformative potential to help patients with a wide range of diseases.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Director

Senior

Employees by Department

City Therapeutics has 23 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore City Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-11-08	4	$135,000,000

Funding Insights

$135,000,000

Total funding amount

$135,000,000

Most recent funding amount

Number of funding rounds

City Therapeutics Tech Stack

Discover the technologies and tools that power City Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

jQuery CDN

CDN

reCAPTCHA

Security

Microsoft 365

Cloudflare

CDN

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

Stimulus

JavaScript frameworks

HSTS

Security

Adobe Fonts

Font scripts

Emotion

Development

Squarespace Commerce

Ecommerce

Frequently asked questions

City Therapeutics is located in US.

City Therapeutics generates an estimated annual revenue of $5,475,520. This revenue figure reflects the company's market position and business performance in its industry.

City Therapeutics has an estimated valuation of $17,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

City Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

City Therapeutics has raised a total of $135,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at City Therapeutics

Fred Briones

Senior Director Cmc

Nicolas Lonfat

Director, Biology

Andy Hoss

Director, Data Science

Jay Wang

Associate Director

Guoqing Sheng

Senior Medical Director

Noriyuki Kawahata